Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2026-04-10 @ 1:08 AM
Study NCT ID:
NCT07040059
Status:
RECRUITING
Last Update Posted:
2025-06-26
First Post:
2025-06-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Sponsor:
Aurigene Discovery Technologies Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AUR103-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None